The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Column Group Ii Management, Lp since year 2005.
The trader's CIK number is 1783952.
At the time of the last reporting, Column Group Ii Management, Lp was the 10% Owner of Rapt Therapeutics, Inc. .
(stock ticker symbol RAPT).
See this page for all insider trading activities at Rapt Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-04||RAPT||Rapt Therapeutics, Inc.||Buy||625,000||12.00||7,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Column Group Ii Management, Lp (10% Owner of Rapt Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.